Wirostko Barbara 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Mar 1, 2018
Insider Transaction Report
Form 4
Wirostko Barbara
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2018-02-28+25,000→ 25,000 totalExercise: $0.57Exp: 2028-02-28→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on February 28, 2019, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.